MARKET

BNTC

BNTC

Benitec
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.22
-0.10
-1.81%
Closed 16:00 02/21 EST
OPEN
5.51
PREV CLOSE
5.24
HIGH
5.51
LOW
4.950
VOLUME
17.92K
TURNOVER
--
52 WEEK HIGH
22.70
52 WEEK LOW
4.130
MARKET CAP
67.08M
P/E (TTM)
2.356
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BNTC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

BNTC News

More
  • Mid-Afternoon Market Update: Dow Rises 70 Points; vTv Therapeutics Shares Jump
  • Benzinga · 02/10 19:48
  • TCO, NNVC, GPOR and JE among midday movers
  • Seeking Alpha - Article · 02/10 17:38
  • Mid-Day Market Update: Crude Oil Down Over 1%; Taubman Centers Shares Spike Higher
  • Benzinga · 02/10 17:23
  • Mid-Morning Market Update: Markets Open Higher; Allergan Tops Q4 Expectations
  • Benzinga · 02/10 15:13

Industry

Biotechnology & Medical Research
+0.37%
Pharmaceuticals & Medical Research
+0.54%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About BNTC

Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. Its In-house product candidates include TT-034, BB-HB-331, BB-AMD-211 and ddRNAi therapeutic. It is focused on commercialization by licensing and partnering of patents and licenses in biotechnology, in functional genomics, with applications in biomedical research and human therapeutics. It has a pipeline of in-house and partnered therapeutic programs based on its patented gene-silencing technology, deoxyribonucleic acid (DNA)-directed ribonucleic acid interference (ddRNAi). The Company is engaged in developing treatments for chronic human conditions, such as hepatitis B, wet age-related macular degeneration (AMD), and oculopharyngeal muscular dystrophy (OPMD) based on this technology.
More

Webull offers kinds of Benitec Biopharma Ltd stock information, including NASDAQ:BNTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTC stock news, and many more online research tools to help you make informed decisions.